active: true
branding:
    logo_url: https://api.polygon.io/v1/reference/company-branding/cmVkaGlsbGJpby5jb20/images/2025-04-04_logo.svg
cik: 0001553846
composite_figi: BBG003RY91S7
currency_name: usd
description: 'Redhill Biopharma Ltd is a specialty biopharmaceutical company focused
    on gastrointestinal diseases. The company is dedicated to advancing its development
    pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related
    products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin)
    and Aemcolo (rifamycin). Currently, the company''s pipeline consists of five therapeutic
    candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of
    which are in clinical development.'
homepage_url: https://www.redhillbio.com
list_date: '2013-01-07'
locale: us
market: stocks
market_cap: 3190759.0845
name: Redhill Biopharma Ltd.
primary_exchange: XNAS
round_lot: 100
share_class_figi: BBG003RY92J5
share_class_shares_outstanding: 2295345
ticker: RDHL
ticker_root: RDHL
total_employees: 35
type: ADRC
weighted_shares_outstanding: 2295345
